Compare Perdana Gapuraprima Tbk. (GPRA) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Perdana Gapuraprima Tbk. vs Merck Tbk. — how do they compare? Perdana Gapuraprima Tbk. trades at Rp99 (market cap 423.39B, 832.2K 24h volume), while Merck Tbk. trades at Rp3,830 (market cap 1.7T, 13.7K 24h volume). The key difference: Merck Tbk. is far larger — about 4× Perdana Gapuraprima Tbk.'s market cap, and Perdana Gapuraprima Tbk. is more actively traded (832.2K versus 13.7K). Which is the better fit depends on your goals.
| GPRA | MERK | |
|---|---|---|
Market Cap | 423.39B | 1.7T |
Volume | 832.2K | 13.7K |
Lot | 8.32K | 137 |
Turnover | 82.59M | 52.45M |
Average Price | 99.24 | 3,828.69 |
Value | 82.59M | 52.45M |
Indicative Equilibrium Price | 100 | 3,850 |
Indicative Equilibrium Volume | 685 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Perdana Gapuraprima Tbk.
PT Perdana Gapuraprima Tbk was established at Jakarta under the name of PT Perdana Gapura Mas on May 21, 1987. The Company’s articles of association has been amended several times, most recently by notarial deed No. 109 of Mrs. Leolin J, S.H., dated Jun 29, 2007, concerning among others, the change in the Company’s name, paid up capital and public offering of stock.
Read more on GPRA →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
